相关实验视频
Updated: Sep 9, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.8K
激活CISD2作为防治多克索鲁比引起的心脏毒性的策略
Yi-Ju Chou1, Chi-Hsiao Yeh2, Chian-Feng Chen3
1Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, 350, Taiwan.
Redox biology
|August 28, 2025
概括
作为CISD2激活剂的hesperetin通过上调CISD2来防止多克索鲁的心脏毒性. 这一发现为化疗患者提供了潜在的治疗策略.
科学领域:
- 心脏病学
- 药理学
- 分子生物学
背景情况:
- 多克索鲁素化疗会引起心脏毒性,这是一个重大的临床挑战.
- 在衰老期间,CISD2蛋白对保持心脏健康至关重要.
研究的目的:
- 调查CISD2激活剂hesperetin是否可以预防多克索鲁比引起的心脏毒性.
- 通过上调CISD2来探索素保护作用的机制.
主要方法:
- 使用急性和瘤携带的小鼠模型对多克索鲁比辛的心脏有毒性.
- 使用过度表达CISD2的转基因小鼠和使用素的药理活性.
- 进行了全面的生物学,组织学,转录学和代谢学分析,包括人类iPSC衍生的心肌细胞.
主要成果:
- 多克索鲁比辛抑制了CISD2,导致心脏功能障碍;CISD2过度表达减轻了这种情况.
- 赫斯佩雷丁维持CISD2水平,改善心脏功能而不会影响多克索鲁比的抗癌作用.
- 增强心脏新陈代谢和抗氧化能力,并保护人类心肌细胞.
结论:
- 对于多克索鲁比辛的心脏毒性,CISD2具有保护作用.
- 赫斯佩雷丁是一种有前途的治疗药物,可缓解多克索鲁比引起的心脏损伤.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Heart Failure Drugs: Inotropic Agents
717
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
717
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K

